Top

Primary and Secondary Packaging of Prescription Medications

Active

Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)View Agency

NAICS

325413 - In-Vitro Diagnostic Substance ManufacturingView NAICS

Place of Performance

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedFeb 4

subcontract

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

AgencyDepartment Of Veterans Affairs → Nac Pharmaceuticals (36E797)

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Bottling, labeling, and barcoding of prescription drugs in compliance with HDA, DSCSA, and VA BCMA standards.

Similar Contracts

Same NAICS industry code

NAICS: 325413

New

DIBBS

KIT, PERFORMANCE QUALIF

Solicitation # SPE2DS-26-T-284S

This contract specifies the procurement of a Performance Qualification Kit for Electrochemiluminescence (ECL) use with the MSD PR2 Model 1800, comprising ten plates and associated reagents. The item is classified as a Type I (Code H) product with a non-extendable shelf life of twelve months and must be stored at room temperature. It is regulated by the FDA, and bidders are required to clearly state the source and part number being supplied, with the manufacturer identified as Meso Scale Diagnostics LLC under part number ECL-PR2-PQ. The National Stock Number is 6550-01-694-0651, and the unit of issue is a single kit. The contract mandates strict adherence to commercial packaging standards as outlined in MEDICAL MARKING STANDARD NO. 1, which supersedes MIL-STD-129, and all packaging must ensure protection against damage during transit. The material must be marked per the specified standard and palletized in compliance with DLA packaging requirements. Delivery is required within five days of contract award, with FOB destination and zero variance allowed on quantity. The inspection and acceptance points are both at the destination, and the shipment must be sent to the specified APO address with an alternate freight shipping address in Yokota AB, Japan. The contract references DLA technical and quality requirements incorporated by reference, including RS011, RP001, and RQ011, and applies all medical acquisition packaging rules. The solicitation number is SPE2DS-26-T-284S, with a response deadline of August 4, 2026, and the required delivery date is July 31, 2026. The contracting office is under the Department of Defense, Medical Supply Chain MD Surg FSF, with Tiffany Parker as the primary point of contact. All packaging, marking, and shipping must comply with MIL-STD-2073-1E and DLA procedural notes for transportation and delivery.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

TEST KIT, CHLAMYDIA TRA

Solicitation # SPE2DS-26-T-281C

This contract is for the procurement of a qualitative direct immunofluorescence test kit designed for the detection of Chlamydia trachomatis in human urogenital and ocular specimens, as well as for confirming Chlamydiae in cell culture. The kit includes two positive control slides, mounting fluid, and the Chlamydia test reagent, ensuring reliable and standardized diagnostic capability. The item is identified by NSN/Part Number 6550-01-725-3600, with a single kit ordered under Purchase Request 7017651737. Delivery is expected within 20 days after order. The solicitation, numbered SPE2DS-26-T-281C, was posted on July 28, 2026, with responses due by August 3, 2026, under a federal procurement process managed by the Department of Defense through the Medical Supply Chain MD Surg FSF office. The place of performance is listed as APO with ZIP code 09094-3219, indicating military or overseas delivery. The primary point of contact is Mary-Kathryn Donahue, reachable via email and phone for inquiries. The NAICS code 325413 classifies this as a pharmaceutical and medicine manufacturing activity, affirming the technical and regulatory standards applicable to the test kit's production and distribution.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

TEST KIT, BACTERIA DETE

Solicitation # SPE2DS-26-T-278C

The test kit is a single-use, self-contained system designed for the rapid detection of coliforms, E. coli, and hydrogen sulfide-producing Enterobacteriaceae such as Salmonella and Citrobacter in food, beverages, and water samples. It incorporates a specialized gelling agent that enables both presence/absence testing and quantification of colony forming units with a sensitivity of 1 CFU per 100 mL in water and 1 CFU per 3 mL in juice, delivering results within 28 hours. The unit of issue is PG, with 25 kits per package, and it is identified by NSN 6550-01-723-3649. The product must comply with mandatory technical and quality requirements referenced in the DLA Master List and adhere to medical packaging standards, specifically Medical Marking Standard No. 1, which replaces MIL-STD-129. Each unit must be sealed in a protective container and shipped in commercial exterior packaging suitable for safe delivery via common carrier at the lowest cost to the specified delivery point at Fort Bragg, NC. The item has a non-extendable shelf life of six months, with no more than one month elapsed between manufacture and government delivery. Storage and shipping must occur at 15 to 25 degrees Celsius, and all labels must include the manufacture date, expiration date, retest date, contract number, and lot number, formatted per the latest MMS1C guidelines. Bidders are required to specify the source and part number being offered, and the solicitation under contract number SPE2DS-26-T-278C closes on August 3, 2026, with delivery expected within 20 days after award.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Solicitation # SPE2DS-26-T-282G

The CONTROL LOOP SET is a microbiological control culture item specifically designed for Streptococcus pyogenes ATCC 19615, intended for use in laboratory quality control procedures. It requires refrigerated storage between 2 to 8 degrees Celsius and must not be frozen. Each package contains five units, designated as one PG (package), and must be packaged and marked in strict compliance with Medical Marking Standard No. 1, replacing all references to MIL-STD-129. The item has a non-extendable shelf life of 15 months, with no more than two months allowed to have passed from the date of manufacture to the date of delivery to the government. All labels must clearly display the date of manufacture, expiration or retest date, and the contract or lot number, following the latest revision of MMS1C. This item is subject to DLA packaging and labeling requirements, and all supplies must be properly sealed and packed in commercial-grade containers suitable for safe transport by common carriers at the lowest cost to the designated delivery point, which is APO 09094-3219. The procurement is governed by technical and quality requirements identified in the DLA Master List and is classified as a TYPE I (CODE J) item under shelf-life regulation RS012. The National Stock Number is 6550-01-691-8597, with a single package ordered under purchase request 7017651773, and delivery is required within five days of award.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

TEST KIT, CORONAVIRUS D

Solicitation # SPE2DS-26-T-280F

The contract is for the procurement of 5 cases of Abbott BinaxNOW COVID-19 Antigen Self Tests, each case containing 12 kits with two tests per kit, for at-home, over-the-counter use. Each test kit must be stored between 2°C and 30°C and must have a shelf life of exactly 12 months with no extensions permitted, and no more than one month may have passed from the date of manufacture to the date of delivery to the government. All units must be packaged commercially in sealed containers that protect against damage, with exterior shipping containers suitable for safe, cost-effective delivery via common carriers. Labeling must comply with Medical Marking Standard No. 1, including the date of manufacture, expiration date, contract number, and lot number, and all government identification must be removed from non-accepted supplies. Technical and quality requirements referenced in the DLA Master List of Technical and Quality Requirements are incorporated by inclusion, and the items are subject to the DLA packaging standards and marking specifications. The contract is tied to NSN 6550-01-716-1573, with a delivery requirement within 20 days after order, and falls under the solicitation SPE2DS-26-T-280F issued by the Department of Defense, with primary point of contact at DLA Troop Support.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Illumina Respiratory Virus Enrichment Kit, MiSeq Reagent Nano Kit, and PhiX Control

Solicitation # N6311626Q0555

The Naval Health Research Center in San Diego, California, intends to award a sole-source contract to ILLUMINA, INC. under the statutory authority of 10 U.S.C. 3204(a)(1), which permits procurement from only one responsible source. The contract is for the supply of specific laboratory reagents and kits including the Illumina Respiratory Virus Enrichment Kit Set A with 96 indexes and 96 samples, the MiSeq Reagent Nano Kit v2 (300-cycles), and the PhiX Control v3. These materials are essential for respiratory virus research and genomic sequencing activities conducted at the center. Although this is a notice of intent and not a formal request for proposals, the government will consider any responses from responsible sources that submit timely and complete information. All potential responders must be registered in SAM.gov and have completed all required FAR and DFARS representations and certifications. Deliveries are scheduled to occur between September 2, 2026, and March 2, 2027. Submissions must reference solicitation number N6311626Q0555 and include the company name, full address, CAGE code, and detailed point of contact information consisting of name, phone number, and email address. The primary point of contact for this procurement is David L. Hill, and the place of performance is in San Diego, California. Responses are due by August 5, 2026, and all submissions must adhere to the specified format and documentation requirements to be considered.

Naval Health Research Center

POSTED

DEADLINE

GLA VA - 10X Genomics Visium HD kit - Genomics Reagents

Solicitation # 36C26226Q1264

The Department of Veterans Affairs is seeking a qualified small business vendor to supply a 10X Genomics Visium HD kit for spatial single-cell RNA sequencing in support of Dr. Philip Scumpia’s research. The solicitation, identified as 36C26226Q1264, is a small business set-aside under NAICS code 325413 for genomics reagents, with a response deadline of August 18, 2026. The required products include the Visium HD Mouse Transcriptome kit with 8 reactions and the Visium CytAssist Alignment Aid Kit, both of which must be U.S.-made or from designated country end products under federal trade agreements. Proposals must include a formal quote, a letter of authorization from the manufacturer, and full vendor details including business size, socioeconomic classification, UEI number, and confirmation of authorized distributor status if applicable. The contract is being managed by the VA office in Long Beach, California, with performance to occur in Los Angeles, and all inquiries should be directed to Sabrina Schofield.

262F Nco 22 Nonary VA Care (00262F)

POSTED

DEADLINE

TEST KIT, E COLI DETECT

Solicitation # SPE2DS-26-T-276M

The contract is for the procurement of Colilert-18 test kits designed to detect both total coliforms and Escherichia coli in water or fecal coliforms in wastewater, with results available within 18 hours. The kits must be stored between 2 and 25 degrees Celsius and protected from light. The product is regulated by the FDA, requiring a referral to a product specialist for confirmation prior to award. The items must be supplied with an identified source and part number, specifically IDEXX DISTRIBUTION INC P/N 98-00876-00 or IDEXX LABORATORIES INC P/N 98-08876-00, and must comply with all applicable technical and quality requirements referenced in the DLA Master List. A shelf life of 15 months, non-extendable, is mandated under RS001 for TYPE I (CODE J) items. Packaging and labeling must adhere to the Medical Marking Standard No. 1, superseding MIL-STD-129, with each unit sealed in a protective container and packed in commercial shipping containers suitable for safe transit at the lowest possible rate. The unit of issue is PG, with a total quantity of 3 packs required. Delivery is FOB destination within 20 days, with zero variance allowed in quantity. The delivery address is Peterson Air Force Base, Colorado, and shipping must be conducted via traceable means, explicitly excluding parcel post. All packaging and marking must comply with the latest version of the DLA Medical Marking Standard, and the contract is subject to Defense Federal Acquisition Regulation Supplement requirements including potential handling of covered defense information. The solicitation number is SPE2DS-26-T-276M with a response deadline of August 3, 2026, and the original required delivery date is July 29, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Combined Synopsis Solicitation- Acquire 32-sample

Solicitation # 75N98026Q00881

The National Institutes of Health, through the Department of Health and Human Services, is soliciting proposals under a non-competitive combined synopsis and solicitation for the acquisition of a 32-sample product, identified by solicitation number 75N98026Q00881. This procurement is conducted under FAR Part 12.603 as a streamlined process for commercial items and falls below the simplified acquisition threshold, utilizing statutory authority under 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii) to justify the absence of full and open competition. The solicitation is issued as a Notice of Intent and serves as the only formal request for proposals, with no additional written solicitation to follow. Proposals must be submitted by the deadline of August 3, 2026, at 6:00 p.m. Eastern Time, following the posting date of July 27, 2026. The contracting activity is managed by the Office of Acquisition and Logistics Operations in Bethesda, Maryland, with the NAICS code 325413 indicating the product relates to pharmaceutical and medicine manufacturing. The primary point of contact for inquiries is Cassie M. Runner, reachable via email at cassie.runner@nih.gov or phone at 301-480-8827. The place of performance has not been specified, but the contract award will be directed toward a commercial supplier capable of meeting requirements without competitive bidding, in alignment with the streamlined procedures and statutory exceptions under federal acquisition regulations. All responses must comply with the terms outlined in the combined synopsis, and no further documentation will be issued beyond this notice.

National Institutes Of Health Olao

POSTED

DEADLINE

TEST KIT, CORONAVIRUS D

Solicitation # SPE2DS-26-T-269U

The contract specifies the procurement of 3 cases of Abbott BinaxNOW COVID-19 Antigen Self Test kits, each case containing 12 kits with two tests per kit, for at-home, over-the-counter use. Each test kit must be stored between 2 and 30 degrees Celsius and is subject to a strict 12-month shelf life with no extensions permitted; no more than one month may have passed from the date of manufacture to the date of delivery to the government. All kits must be labeled with the date of manufacture, expiration or retest date, and the contract and lot numbers in compliance with Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must meet commercial standards, ensuring protection from damage and safe delivery via common carrier to the designated delivery point in FPO, 96674, while minimizing shipping costs. The item is identified by NSN 6550-01-716-1573 under solicitation SPE2DS-26-T-269U, with a 20-day delivery requirement and a response deadline of August 3, 2026. Technical and quality requirements referenced by R or I numbers are governed by the DLA Master List, and the procurement is subject to covered defense information protocols and DLA packaging standards.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Solicitation # SPE2DS-26-T-270X

The contract is for a CONTROL LOOP SET, specifically designed for microbiology use with Streptococcus pyogenes ATCC 19615, requiring refrigerated storage between 2°C and 8°C (36°F to 46°F) and prohibiting freezing. Each package contains five units, sold as a single purchasing unit (PG), and the item carries a non-extendable shelf life of 15 months, with no more than two months allowed to have elapsed from the date of manufacture to delivery. All labeling must comply with MMS1C, including explicit markings for the date of manufacture, expiration or retest date, and the contract or lot number. Packaging guidelines follow commercial standards and the Medical Marking Standard No. 1, which supersedes MIL-STD-129 for medical acquisitions; exterior shipping containers must ensure safe delivery at the lowest freight rate using traceable carriers, with parcel post strictly prohibited. The item is governed by a suite of DFARS and FAR clauses, including requirements for safeguarding covered defense information, cyber incident reporting, NIST SP 800-171 compliance, and restrictions on covered telecommunications equipment. Transportation must comply with maritime regulations favoring U.S.-flag vessels. Quality and technical specifications are derived from the DLA Master List of Technical and Quality Requirements, and packaging must meet RP001 DLA standards, including proper preservation per MIL-STD-2073-1E to maintain product integrity. The item is subject to destination inspection under FAR 52.246-2, with acceptance performed by the Government. The solicitation, issued under number SPE2DS-26-T-270X, has a response deadline of August 3, 2026, and requires electronic submission via DIBBS. The delivery point is identified as a Department of Defense address in Hampton, Virginia, with an overall delivery window of 20 days after the actual delivery order. Pricing varies by quantity, with extended contract values reaching up to $11,853.76 based on multiple line items. Contractors must have an active UEI and CAGE code, represent their size and socioeconomic status accurately, and comply with anti-trafficking, employment eligibility, and sustainable product requirements. All payment submissions must be processed through WAWF, and the contract prohibits the use of mandatory arbitration agreements and restricts compensation for former DoD officials.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

FY26 FR0 DFS/PHL - Roche Flu Surveillance Testing ReagentThe contract anticipates the procurement of testing reagents for influenza surveillance under the Forensic Sciences Division of the District of Columbia for fiscal year 2026. The initiative is part of a broader public health effort to monitor flu activity, with reagents intended for use in diagnostic and surveillance testing. While specific quantities, delivery timelines, or technical specifications are not detailed in the forecast, the reagents will support laboratory-based detection and analysis of influenza strains across the jurisdiction. This procurement is categorized as a forecast, indicating it is a planning tool for vendors to prepare for an upcoming solicitation, and no formal solicitation number has been issued as of the posting date. The agency responsible, DFS, is based in Washington D.C., and performance is expected to occur within the district, though no specific location is provided. Vendors interested in participating should monitor future official solicitations, as this forecast serves only as an early indicator of intent and does not constitute a binding request for proposals.

Forensic Sciences (DFS)

POSTED

7 days ago

DEADLINE

N/A

View Details

More opportunities from Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

Same awarding agency

NAICS: 541611

New

Federal

Small Business Subcontracting Plan Development & ReportingThe contract requires the development, implementation, and ongoing reporting of a small business subcontracting plan that fully complies with Veterans Affairs guidelines, using the electronic Subcontracting Reporting System eSRS. The work must be performed in alignment with the NAICS code 541611, which pertains to management consulting services, and the plan must be designed to meet federal obligations for small business participation under VA procurement regulations. The contractor will be responsible for ensuring accurate data submission, proper classification of subcontractor types, and adherence to all VA-specific reporting standards throughout the duration of the project. The solicitation is issued under the Department of Veterans Affairs through Nac Pharmaceuticals and has a response deadline of August 13, 2026, with the opportunity posted on July 28, 2026. There is no specified set-aside type, and the place of performance and point of contact details are not provided. The contractor must be prepared to operate within the VA’s compliance framework, maintain transparent records of small business subcontracting efforts, and generate regular, auditable reports through eSRS to demonstrate progress and adherence to federal goals for small business inclusion. The successful bidder will need expertise in federal subcontracting compliance, experience with VA systems and reporting protocols, and a thorough understanding of eSRS workflows and deadlines.

Administrative Management and General Management Consulting Services

POSTED

DEADLINE

Logistics and Distribution to PPV CentersThe contract pertains to the logistics and distribution of finished pharmaceuticals under FOB Destination terms to Department of Veterans Affairs and Department of Defense Prime Vendor distribution centers across the United States, ensuring timely and compliant delivery to federal healthcare supply nodes. It is structured as a subcontract with a NAICS code of 484220, indicating a focus on specialized freight logistics, and is issued by Nac Pharmaceuticals under the authority of the Department of Veterans Affairs. The solicitation is open for responses until August 13, 2026, with a firm deadline of 7:30 PM Eastern Time, requiring proposers to meet strict operational, regulatory, and supply chain standards to qualify for award, particularly around cold chain management, inventory accuracy, and federal delivery protocols. Delivery must align with federal procurement requirements, including traceability, security, and compliance with federal药品 regulations, and performance is expected nationwide without geographic restriction within the U.S.

Specialized Freight (except Used Goods) Trucking, Local

POSTED

DEADLINE

Serialization and DSCSA Compliance ServicesNac Pharmaceuticals is seeking a subcontractor to provide comprehensive serialization and DSCSA compliance services, including full end-to-end implementation of GS1 Data Matrix encoding for product units, handling of EPCIS transaction data to ensure traceability across the pharmaceutical supply chain, and integration with the NABP directory for accurate verification and validation of product information. The work requires strict adherence to federal serialization regulations to support secure, interoperable tracking of pharmaceuticals from manufacturer to dispenser, with all data properly formatted and transmitted in compliance with DSCSA milestones. Subcontractors must demonstrate technical capability in GS1 standards, EPCIS messaging protocols, and NABP system integration to meet the operational demands of a major federal healthcare provider. The opportunity is posted under NAICS code 541330 and has a response deadline of August 13, 2026, with no set-aside classification specified. While the place of performance and point of contact are not detailed, the contract is tied to the Department of Veterans Affairs through Nac Pharmaceuticals as the prime contractor.

POSTED

DEADLINE

Pharmaceutical Packaging Materials SupplyNac Pharmaceuticals is seeking a subcontractor to supply high-density polyethylene (HDPE) bottles, child-resistant caps, and compliant labels for unit-of-use pharmaceutical packaging. The materials must meet stringent pharmaceutical standards to ensure safety, compliance, and functionality in a unit-dose format, with particular emphasis on child-resistant features and regulatory labeling requirements. The procurement is classified under NAICS code 326199, indicating it pertains to other plastic product manufacturing, and the anticipated contract award is intended to support the Department of Veterans Affairs' pharmaceutical distribution needs. Interested parties must submit responses by August 13, 2026, at 7:30 PM Eastern Time, with the solicitation posted on July 28, 2026. The performance location and detailed delivery specifications are not explicitly defined in the posting, but successful bidders will be expected to adhere to all applicable federal pharmaceutical packaging regulations and deliver materials that meet exact quality and certification benchmarks without deviation.

All Other Plastics Product Manufacturing

POSTED

DEADLINE

Tablet Manufacturing and PackagingNac Pharmaceuticals, acting on behalf of the Department of Veterans Affairs, is seeking a subcontractor to manufacture and package pioglitazone 15mg tablets in 30- and 90-tablet unit-of-use bottles under current Good Manufacturing Practices and the Drug Supply Chain Security Act requirements. The work must adhere to strict regulatory standards to ensure product safety, traceability, and compliance with federal pharmaceutical guidelines. The solicitation was posted on July 28, 2026, and responses are due by August 13, 2026, at 7:30 PM Eastern Time. The NAICS code 325412 identifies this as a pharmaceutical and medicinal product manufacturing opportunity. All manufacturing and packaging activities are expected to occur at the contractor’s facility, with no specified place of performance indicated. The contract is structured as a subcontract and is not subject to any set-aside provisions.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

Active Pharmaceutical Ingredient (API) SupplyNac Pharmaceuticals is seeking a subcontractor to supply Pioglitazone Active Pharmaceutical Ingredient (API) that meets USP-NF standards and complies with the Trade Agreements Act for use in the manufacturing of finished dosage forms. The opportunity is posted under NAICS code 325411, indicating classification within pharmaceutical preparation manufacturing, and the response deadline is August 13, 2026, at 7:30 PM Eastern Time. The API must adhere strictly to pharmacopeial specifications to ensure quality, safety, and compatibility with regulatory requirements for final product approval. The place of performance and point of contact details are not specified, suggesting the supplier’s location and logistics are flexible as long as deliverables meet contractual obligations. This procurement is part of a broader initiative by the Department of Veterans Affairs through its contractor Nac Pharmaceuticals, to secure a reliable supply chain for critical drug components in support of federal healthcare programs.

Medicinal and Botanical Manufacturing

POSTED

DEADLINE

6505--Pioglitazone Tablets

Solicitation # 36E79726R0030

The contract titled 6505--Pioglitazone Tablets is a solicitation issued by the Department of Veterans Affairs through Nac Pharmaceuticals with the solicitation number 36E79726R0030, posted on July 28, 2026, and with a response deadline of August 13, 2026, at 7:30 PM ET. The North American Industry Classification System code 325412 identifies this as a pharmaceutical manufacturing contract, specifying the procurement of pioglitazone tablets, a medication used primarily for diabetes management. The office responsible for this solicitation is located in Hines, Illinois, with a ZIP code of 60141, and the place of performance details are not specified. The primary point of contact is Teresa Hussain, Senior Contract Specialist, reachable via email at teresa.hussain@va.gov. There is no set-aside designation indicated for this opportunity, meaning it is open to all eligible vendors without restriction based on small business, veteran-owned, or other classifications. Interested parties must submit proposals through the SAM.gov portal before the deadline to be considered for award.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

Pharmaceutical Logistics and Distribution to Prime Vendors

General Warehousing and Storage

POSTED

DEADLINE

Supply of Metoprolol Tartrate Active Pharmaceutical Ingredient (API)

Medicinal and Botanical Manufacturing

POSTED

DEADLINE

NDC Registration and FDA Compliance Services

Administrative Management and General Management Consulting Services

POSTED

DEADLINE

Manufacturing of Metoprolol Tartrate 25mg Tablets

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

Small Business Subcontracting and Reporting ServicesThis contract involves providing specialized support services to the prime contractor aimed at enhancing their ability to meet small business utilization goals. The services include managing subcontract tracking to ensure accurate monitoring of subcontracts, facilitating compliance with Federal Acquisition Regulation (FAR) reporting requirements, and expediting payment processes to improve cash flow for subcontractors. The work under this subcontract is tailored to align with the specific needs of the prime contractor, ensuring adherence to mandated small business participation and regulatory standards. The contract is titled "Small Business Subcontracting and Reporting Services" and falls under NAICS code 541614, indicating a focus on business management consulting services. It is associated with the Department of Veterans Affairs, specifically through the agency Nac Pharmaceuticals (36E797). While detailed location and contact information are unspecified, the contract demonstrates a clear commitment to supporting governmental agencies in fulfilling small business involvement objectives within their procurement activities. This effort is crucial for maintaining transparency and accountability in subcontracting practices within federal acquisition frameworks.

Process, Physical Distribution, and Logistics Consulting Services

POSTED

6 months ago

DEADLINE

N/A

View Details